Latest News and Press Releases
Want to stay updated on the latest news?
-
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 22, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or...
-
Kailera Therapeutics, Inc. (Nasdaq: KLRA), an advanced clinical-stage biotechnology company, today announced the closing of its initial public offering.
-
WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and...
-
$180 Million Financing Upfront with Up to an Additional $174 Million from Warrants Exercisable Within 20 Days of FDA Approval Transaction led by Frazier Life Sciences, TPG Life Sciences Innovations,...
-
SINGAPORE and NORTH BRUNSWICK, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (Nasdaq: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on...
-
LaFleur has selected Trafigura Canada Limited to arrange and provide a prepayment financing facility of up to C$30 million and gold doré purchase agreement
-
CHICAGO, April 15, 2026 (GLOBE NEWSWIRE) -- Nautilus Solar Energy® LLC, one of the largest community solar businesses in the United States and a major contributor to America’s advancement...
-
NE PEUT ÊTRE DISTRIBUÉ AUX AGENCES DE TRANSMISSION AUX ÉTATS-UNIS NI PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ DIRECTEMENT, OU INDIRECTEMENT, EN TOTALITÉ OU EN PARTIE, AUX ÉTATS-UNIS. QUÉBEC, 15 avr. 2026 ...
-
Kobo Resources Announces Closing of Non-Brokered Private Placement for Gross Proceeds of $5.5 Million and Engagement of Atrium Research
-
WALTHAM, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody...